Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Treating Tobacco Use And Dependence PDF full book. Access full book title Treating Tobacco Use And Dependence.
| Author | : |
| Publisher | : DIANE Publishing |
| Total Pages | : 276 |
| Release | : 2009 |
| Genre | : Nicotine addiction |
| ISBN | : 1437906621 |
| Author | : Michael Fiore |
| Publisher | : Department of Health and Human Services Public Health Servic |
| Total Pages | : 200 |
| Release | : 2000 |
| Genre | : Medical |
| ISBN | : |
"This guideline is an updated version of the 1996 Smoking Cessation Clinical Practice Guideline No. 18."--P. ii.
| Author | : Alan L Peterson |
| Publisher | : Hogrefe Publishing GmbH |
| Total Pages | : 135 |
| Release | : 2011-01-01 |
| Genre | : Psychology |
| ISBN | : 1613343248 |
This volume in the series Advances in Psychotherapy – Evidence-Based Practice provides health care providers with practical and evidence-based guidance on the diagnosis and treatment of nicotine and tobacco dependence. Tobacco use is the leading preventable cause of death in the world, and it is the only legally available consumer product that kills people when used entirely as intended. Research over the past several decades has led to the development of a number of evidence-based treatments for nicotine and tobacco dependence that can be delivered by health care professionals in a variety of primary and specialty care settings. This book aims to increase medical, mental health, and dental practitioners' access to empirically supported interventions for nicotine and tobacco dependence, with the hope that these methods will be incorporated into routine clinical practice. The book is both a compact "how-to" reference for clinicians and an ideal educational resource for students and for practice-oriented continuing education. The volume includes tables, boxed clinical pearls, and clinical vignettes, and the appendix includes clinical tools, patient handouts, and links to the top recommended websites for the download of additional patient materials.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 131 |
| Release | : 2013-04-16 |
| Genre | : Medical |
| ISBN | : 0309264049 |
Tobacco use is the leading cause of preventable death in United States, causing more than 440,000 deaths annually and resulting in $193 billion in health-related economic losses each year-$96 billion in direct medical costs and $97 billion in lost productivity. Since the first U.S. Surgeon General's report on smoking in 1964, more than 29 Surgeon General's reports, drawing on data from thousands of studies, have documented the overwhelming and conclusive biologic, epidemiologic, behavioral, and pharmacologic evidence that tobacco use is deadly. This evidence base links tobacco use to the development of multiple types of cancer and other life-threatening conditions, including cardiovascular and respiratory diseases. Smoking accounts for at least 30 percent of all cancer deaths, and 80 percent of lung cancer deaths. Despite the widespread agreement on the dangers of tobacco use and considerable success in reducing tobacco use prevalence from over 40 percent at the time of the 1964 Surgeon General's report to less than 20 percent today, recent progress in reducing tobacco use has slowed. An estimated 18.9 percent of U.S. adults smoke cigarettes, nearly one in four high school seniors smoke, and 13 percent of high school males use smokeless tobacco products. In recognition that progress in combating cancer will not be fully achieved without addressing the tobacco problem, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened a public workshop, Reducing Tobacco-Related Cancer Incidence and Mortality, June 11-12, 2012 in Washington, DC. In opening remarks to the workshop participants, planning committee chair Roy Herbst, professor of medicine and of pharmacology and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital, described the goals of the workshop, which were to examine the current obstacles to tobacco control and to discuss potential policy, outreach, and treatment strategies that could overcome these obstacles and reduce tobacco-related cancer incidence and mortality. Experts explored a number of topics, including: the changing demographics of tobacco users and the changing patterns of tobacco product use; the influence of tobacco use on cancer incidence and cancer treatment outcomes; tobacco dependence and cessation programs; federal and state level laws and regulations to curtail tobacco use; tobacco control education, messaging, and advocacy; financial and legal challenges to tobacco control efforts; and research and infrastructure needs to support tobacco control strategies, reduce tobacco related cancer incidence, and improve cancer patient outcomes. Reducing Tobacco-Related Cancer Incidence and Mortality summarizes the workshop.
| Author | : Michael Fiore |
| Publisher | : Department of Health and Human Services Public Health Servic |
| Total Pages | : 202 |
| Release | : 2000 |
| Genre | : Medical |
| ISBN | : |
"This guideline is an updated version of the 1996 Smoking Cessation Clinical Practice Guideline No. 18."--P. ii.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 381 |
| Release | : 2009-10-21 |
| Genre | : Medical |
| ISBN | : 0309146844 |
The health and economic costs of tobacco use in military and veteran populations are high. In 2007, the Department of Veterans Affairs (VA) and the Department of Defense (DoD) requested that the Institute of Medicine (IOM) make recommendations on how to reduce tobacco initiation and encourage cessation in both military and veteran populations. In its 2009 report, Combating Tobacco in Military and Veteran Populations, the authoring committee concludes that to prevent tobacco initiation and encourage cessation, both DoD and VA should implement comprehensive tobacco-control programs.
| Author | : Michelle N. Eakin |
| Publisher | : Springer Nature |
| Total Pages | : 302 |
| Release | : 2023-02-28 |
| Genre | : Medical |
| ISBN | : 3031249143 |
This book is a guide to pharmacotherapy treatment of tobacco dependence. The 2020 American Thoracic Society clinical practice guidelines on treating tobacco dependence serves as the cornerstone for this work with its robust discussion of recommended treatment options and how to tailor treatment to specific patient populations. Tobacco dependence remains a major health concern for many adults and given the dramatic increase of youth electronic cigarette use, clinicians need a singular resource to treat these different populations. This book addresses that by following the three main points of how to best address the adverse impact of tobacco use on public health: 1) prevent initiation of tobacco use; 2) understand mechanisms of addiction; 3) effectively treat tobacco dependence. The book begins by describing the current patterns of product use, the adverse impact of tobacco on global health, and tobacco-related health disparities. Authors discuss both combustible and electronic tobacco products, as well as current research on the adverse impact of vaping and associated flavorings including menthol, role of the e-cigarette in cessation, and treatment of adolescent nicotine dependence. Chapters conclude with a discussion of specific tobacco control policies to improve overall public health. This is an ideal guide for pulmonologists, pediatricians, primary care physicians and other specialty providers who see patients with nicotine dependence. This book is also of interest to public health professions to help inform public health campaigns and treatment offerings to reduce overall tobacco product use through prevention and treatment.
| Author | : David B. Abrams |
| Publisher | : Guilford Press |
| Total Pages | : 146 |
| Release | : 2003-02-12 |
| Genre | : Psychology |
| ISBN | : 9781572308497 |
This unique clinical handbook offers the knowledge, skills, and materials needed to help all types of smokers, even the most hard-core, successfully quit. Provided are assessment tools, treatment planning guidelines, and a series of complete treatment packages, ranging from ultra-brief to more intensive options. Designed for use in a variety of settings by a wide range of providers, the volume is evidence-based and consistent with the latest national guidelines on best practice. The authors, leading scientist-practitioners, incorporate the latest pharmacotherapeutic approaches as well as proven motivational, cognitive, and behavioral techniques. Strategies are presented for tailoring treatment to individual smokers and for preventing relapse. Also included are session-by-session intervention guidelines, helpful case examples, and dozens of requisite handouts and forms, ready to photocopy and use. Key Features No other book presents the full range of empirically supported treatments. Practical: includes step-by-step guidelines, cases, reproducible patient forms. Consistent with best-practice recommendations issued by the Surgeon General, the American Psychiatric Association, and the British Thoracic Society. Describes approaches with and without pharmacotherapy. Photocopy Rights: The Publisher grants individual book purchasers nonassignable permission to reproduce selected materials in this book for professional use. For details and limitations, see copyright page.
| Author | : U. S. Department Human Services |
| Publisher | : CreateSpace |
| Total Pages | : 36 |
| Release | : 2013-06-21 |
| Genre | : Medical |
| ISBN | : 9781490500461 |
The Quick Reference Guide for Clinicians contains strategies and recommendations from the Public Health Service-sponsored Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update. The guideline was designed to assist clinicians; smoking cessation specialists; and healthcare administrators, insurers, and purchasers in identifying and assessing tobacco users and in delivering effective tobacco dependence interventions. It was based on an exhaustive systematic review and analysis of the extant scientific literature from 1975–2007 and uses the results of more than 50 meta-analyses. The Quick Reference Guide for Clinicians summarizes the guideline strategies for providing appropriate treatments for every patient. Effective treatments for tobacco dependence now exist, and every patient should receive at least minimal treatment every time he or she visits a clinician. The first step in the process—identification and assessment of tobacco use status—separates patients into three treatment categories: (1) tobacco users who are willing to quit should receive intervention to help in their quit attempt; (2) those who are unwilling to quit now should receive interventions to increase their motivation to quit; and (3) those who recently quit using tobacco should be provided relapse prevention treatment. Tobacco is the single greatest cause of disease and premature death in America today, and is responsible for more than 435,000 deaths annually. About 20 percent of adult Americans currently smoke, and 4,000 children and adolescents smoke their first cigarette each day. The societal costs of tobacco related death and disease approach $96 billion annually in medical expenses and $97 billion in lost productivity. However, more than 70 percent of all current smokers have expressed a desire to stop smoking; if they successfully quit, the result will be both immediate and long-term health improvements. Clinicians have a vital role to play in helping smokers quit. The analyses contained within the Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update demonstrated that efficacious treatments for tobacco users exist and should become a part of standard care giving. Research also shows that delivering such treatments is cost-effective. In summary, the treatment of tobacco use and dependence presents the best and most cost-effective opportunity for clinicians to improve the lives of millions of Americans nationwide.
| Author | : United States. Public Health Service. Office of the Surgeon General |
| Publisher | : |
| Total Pages | : 728 |
| Release | : 2010 |
| Genre | : Government publications |
| ISBN | : |
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
